SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matria Healthcare (MATR) -- Ignore unavailable to you. Want to Upgrade?


To: GREATMOOD who wrote (111)2/17/1998 10:45:00 AM
From: GREATMOOD  Read Replies (1) | Respond to of 220
 
EARNINGS LOOK GOOD!

Zacks estimated $0 .13 and Matria came in with $0.14 cents!

GM

Matria Healthcare, Inc. Announces Fourth Quarter & Year-End Results

MARIETTA, Ga., Feb. 17 /PRNewswire/ -- Matria Healthcare, Inc., (Nasdaq: MATR), today announced its financial results for the fourth quarter and the year ended December 31, 1997.

Revenues for the fourth quarter of 1997 increased to $37.1 million, compared to $36.2 million reported in the fourth quarter of 1996. Net income for the quarter, excluding amortization of goodwill and other intangibles, was $5.0 million, or $0.14 per share, which was 201% over the fourth quarter of 1996 net income of $2.5 million, or $0.07 per share, excluding these amortization expenses and restructuring charges. Including the amortization of goodwill and other intangibles of $9.1 million ($0.25 per share), the Company reported a net loss of $4.1 million, or $0.11 per share, for the fourth quarter of 1997, which was 29% of the net loss of $14.1 million, or $0.39 per share, for the fourth quarter of 1996.

For the year ended December 31, 1997, the Company had revenues of $144.5 million, an increase of 10% over the $130.8 million in revenue reported for 1996. Net income for the year was $15.7 million, or $0.43 per share, before deduction of goodwill and other intangible amortization charges of $36.6 million ($1.00 per share), compared to $1.5 million, or $0.05 per share in 1996. Including the deduction of goodwill and other intangible amortization and restructuring charges, the Company's performance for the twelve-month period improved 59% from a loss of $51.1 million, or $1.58 per share, in 1996 to a loss of $20.9 million, or $0.57 per share in 1997.

Donald R. Millard, President and CEO stated, "We have worked diligently on a three-phased agenda since the merger. Our first two phases, focusing on the successful integration of the two companies and obtaining full operational synergies from the merger, are clearly evidenced in our 1997 results. We have achieved in excess of $40 million in annualized cost savings, well ahead of our initial projection of $30 million." Millard further commented, "Our third phase, maximizing the strategic value of the merger, is currently our primary focus."

Frank D. Powers, Executive Vice President and COO added, "The fourth quarter marked the seventh consecutive quarter since the merger in which we produced increased operating earnings before goodwill amortization and restructuring charges. One element of our plan to maximize the merger's strategic value is to concentrate on acute patients and hospital-based selling. As a result, we are seeing a shift in our patient mix to the more acute patients requiring therapeutic interventions which generate greater profit margins. Our fourth quarter results are reflecting the early impact of this focus."

According to Parker H. Petit, Chairman, "Our plan to maximize the strategic value of the merger also involves leveraging Matria's core competency of disease state management into diseases beyond the condition of pregnancy. The recent expansion of our gestational diabetes program provides us with a natural launching point into disease state management of the chronic diabetes population. We expect to implement a comprehensive patient management program for this population later this year. We are very pleased with the 1997 results and look forward to reporting our progress as we expand into other disease states."

This press release contains forward-looking statements that involve risks and uncertainties, including developments in the healthcare industry, third-party actions over which the Company does not have control, and regulatory requirements applicable to the Company's business, as well as other risks detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

Matria Healthcare, Inc. is the leading provider of comprehensive obstetrical homecare and maternity management services to HMOs, indemnity carriers, and employers.

MATRIA HEALTHCARE, INC.

Consolidated Condensed Statements of Operations

(in thousands, except per share data)

(Unaudited)

Three months ended 12/31/97 12/31/96

Revenues $ 37,101 $ 36,205

Cost of revenues 14,281 15,091

Selling and administrative expenses 16,078 16,806

Provision for doubtful accounts 1,776 1,984

Amortization of goodwill and other intangibles 9,147 9,111

Restructuring expenses --- 7,500

Total 41,282 50,492

Operating loss (4,181) (14,287)

Interest income, net 69 269

Other income (expense), net (28) (102)

Net loss $(4,140) (14,120)

Basic and diluted loss per share $ (.11) (.39)

Weighted average shares 36,685 36,258

Twelve months ended 12/31/97 12/31/96

Revenues $144,533 $130,806

Cost of revenues 57,610 55,911

Selling and administrative expenses 65,024 66,775

Provision for doubtful accounts 6,599 7,591

Amortization of goodwill and other intangibles 36,603 30,083

Restructuring expenses --- 22,525

Total 165,836 182,885

Operating loss (21,303) (52,079)

Interest income, net 486 824

Other income (expense), net (85) 134

Net loss $(20,902) (51,121)

Basic and diluted loss per share $ (.57) (1.58)

Weighted average shares 36,527 32,328

MATRIA HEALTHCARE, INC.

Consolidated Condensed Balance Sheets

(Amounts in thousands)

(Unaudited)

ASSETS December 31, December 31,

1997 1996

Current assets:

Cash and short-term investments $ 20,942 $ 24,640

Trade accounts receivable, net 39,601 29,456

Inventories 1,088 867

Other current assets 2,264 1,628

Total current assets 63,895 56,591

Property and equipment, net 12,364 15,220

Goodwill and other intangibles, net 112,149 148,099

Other assets 2,724 3,278

Total $191,132 $223,188

Liabilities and Shareholders' Equity

Current Liabilities:

Current installments of long-term debt and

obligations under capital leases 884 2,521

Accounts payable, principally trade 5,712 6,486

Deferred revenues 3,561 3,402

Other current liabilities 12,586 22,157

Total current liabilities 22,743 34,566

Long-term debt and obligations under capital

leases, excluding current installments 1,712 2,499

Accrued pension costs 5,328 4,096

Other long-term liabilities 8,180 8,849

Total liabilities 37,963 50,010

Shareholders' equity 153,169 173,178

Total $191,132 $223,188

SOURCE Matria Healthcare, Inc.

CO: Matria Healthcare, Inc.

ST: Georgia

IN: HEA

SU: ERN

02/17/98 09:56 EST prnewswire.com